1. Home
  2. AVXL vs FCBC Comparison

AVXL vs FCBC Comparison

Compare AVXL & FCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • FCBC
  • Stock Information
  • Founded
  • AVXL 2004
  • FCBC 1874
  • Country
  • AVXL United States
  • FCBC United States
  • Employees
  • AVXL N/A
  • FCBC N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • FCBC Major Banks
  • Sector
  • AVXL Health Care
  • FCBC Finance
  • Exchange
  • AVXL Nasdaq
  • FCBC Nasdaq
  • Market Cap
  • AVXL 794.0M
  • FCBC 681.6M
  • IPO Year
  • AVXL N/A
  • FCBC 1992
  • Fundamental
  • Price
  • AVXL $10.60
  • FCBC $41.79
  • Analyst Decision
  • AVXL Strong Buy
  • FCBC
  • Analyst Count
  • AVXL 2
  • FCBC 0
  • Target Price
  • AVXL $44.00
  • FCBC N/A
  • AVG Volume (30 Days)
  • AVXL 942.8K
  • FCBC 80.8K
  • Earning Date
  • AVXL 08-05-2025
  • FCBC 07-22-2025
  • Dividend Yield
  • AVXL N/A
  • FCBC 2.97%
  • EPS Growth
  • AVXL N/A
  • FCBC 3.83
  • EPS
  • AVXL N/A
  • FCBC 2.74
  • Revenue
  • AVXL N/A
  • FCBC $162,590,000.00
  • Revenue This Year
  • AVXL N/A
  • FCBC $2.34
  • Revenue Next Year
  • AVXL N/A
  • FCBC $1.10
  • P/E Ratio
  • AVXL N/A
  • FCBC $15.23
  • Revenue Growth
  • AVXL N/A
  • FCBC 1.13
  • 52 Week Low
  • AVXL $4.00
  • FCBC $33.88
  • 52 Week High
  • AVXL $14.44
  • FCBC $49.02
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 75.85
  • FCBC 70.82
  • Support Level
  • AVXL $9.08
  • FCBC $38.81
  • Resistance Level
  • AVXL $9.78
  • FCBC $39.97
  • Average True Range (ATR)
  • AVXL 0.53
  • FCBC 0.95
  • MACD
  • AVXL 0.19
  • FCBC 0.37
  • Stochastic Oscillator
  • AVXL 95.03
  • FCBC 98.65

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

Share on Social Networks: